Humana Rg
HUM
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
12/27/2024 - 16:15:00
Bid
12/27/2024 - 15:59:59
Bid
Volume
Ask
12/27/2024 - 15:59:59
Ask
Volume
255.64
-0.50 ( -0.20% )
255.78
3,700
255.79
100
More information
Analysis by TheScreener
24.12.2024
Evaluation Slightly negative  
Interest None  
Sensibility Middle  
Analysis date: 24.12.2024
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 06.12.2024.
Interest
  None
No interest since 13.12.2024.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 04.10.2024 at a price of 240.03.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
  Negative
 
The forty day Medium Term Technical Trend is negative since 13.12.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is .
4wk Rel Perf
  -16.88%
 
The four week relative underperformance versus SP500 is 16.88%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 01.10.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.79%.
Mkt Cap in $bn
  30.79
With a market capitalization >$8bn, HUMANA is considered a large-cap stock.
G/PE Ratio
  0.46
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
  20.24
The estimated PE is for the year 2026.
LT Growth
  7.65%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  24
Over the last seven weeks, an average of 24 analysts provided earnings per share estimates.
Dividend Yield
  1.56%
The twelve month estimated dividend yield represents 31.54% of earnings forecasts.
Beta
  31
For 1% of index variation, the stock varies on average by 0.31%.
Correlation
  0.12
Stock movements are totally independent of index variations.
Value at Risk
  61.32
The value at risk is estimated at USD 61.32. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002